Nov 8, 2026 · 9 min
Three stocks face defining tests in the week ahead
Week Ahead: Paramount Skydance, Hims & Hers, Take-Two Interactive
The companies’ next milestones hinge on execution, regulation and a major game launch, giving investors distinct risks to weigh.
- 1Paramount Skydance’s first post-acquisition earnings report will test integration progress, synergies and its substantial debt burden.
- 2Hims & Hers’ Eli Lilly partnership could support growth while exposing the telehealth company to regulatory risks around drug supply.
- 3Take-Two’s earnings outlook is closely tied to demand, preorders and the planned launch of Grand Theft Auto VI.
Don't miss
The discussion identifies Grand Theft Auto VI’s planned launch as central to investor expectations for Take-Two Interactive.
The brief
Bloomberg’s Tim Stenovec and Norah Melinda frame the week around three companies whose next milestones could reshape investor expectations: Paramount Skydance, Hims & Hers Health and Take-Two Interactive.
Paramount Skydance faces its first earnings report since acquiring Warner Bros. Discovery, with integration, expected synergies, theatrical commitments and a substantial debt burden under scrutiny.
Hims & Hers’ partnership with Eli Lilly could improve access to weight-loss medications through its telehealth platform, but regulatory concerns around drug supply complicate the growth case.
Take-Two’s outlook turns on the planned launch of Grand Theft Auto VI, as preorders, demand and possible delays shape expectations for the company’s earnings and future performance.
The episode’s central lesson is that each stock carries a different execution test: merger discipline, regulated healthcare expansion or delivering a pivotal game launch.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.